Tirzepatide
Research PeptideAlso known as: Mounjaro, Zepbound
What is Tirzepatide?
Dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes
How It Works
What Research Shows
Key Findings:
Limited Human Research
Most research on Tirzepatide has been conducted in animal models. Human clinical trials are limited or absent. Results may not translate directly to humans.
Dosing Protocol
These are general guidelines based on research literature and community protocols. Individual dosing should be determined by a qualified healthcare provider.
Pharmacokinetics
Pharmacokinetic values are approximate and may vary based on individual factors such as body weight, metabolism, and administration technique.
Safety & Risks
Reported Side Effects:
Contraindications:
Important: This information is for research purposes only. Always consult with a qualified healthcare provider before using any peptide. Never use peptides without proper medical supervision.
Sourcing & Quality
Quality varies significantly between peptide sources. When sourcing Tirzepatide, consider:
- Third-party testing (HPLC, Mass Spectrometry)
- Certificate of Analysis (CoA) availability
- Purity levels (>98% recommended)
- Beware of LPS (endotoxin) contamination
CalcPep does not sell peptides or recommend specific vendors. Always verify product quality through independent testing.
Track Your Protocol
Use CalcPep to calculate doses, log injections, and track your progress.
Get CalcPep